Revvity Expands Access to Base Editing Technology with Aim to Accelerate Discovery to Curenews2023-09-26T11:41:34+00:00September 26th, 2023|Medical Device News Magazine|
PADCEV® (enfortumab vedotin-ejfv) and KEYTRUDA® (pembrolizumab) Significantly Improve Overall Survival and Progression-Free Survival in Patients With Previously Untreated Advanced Bladder Cancer in Pivotal Phase 3 EV-302 Trialnews2023-09-22T11:02:16+00:00September 22nd, 2023|Medical Device News Magazine|
NeuroBo Pharmaceuticals Doses First Patient in Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of NASHnews2023-09-15T14:07:33+00:00September 15th, 2023|Medical Device News Magazine|
Medmain Inc. Has Been Selected for the U.S. Market Gateway Accelerator for BioSciences and MedTechnews2023-09-12T14:50:41+00:00September 12th, 2023|Medical Device News Magazine|
Karger Publishers New Journal – Immune Systemnews2023-09-12T14:21:33+00:00September 12th, 2023|Medical Device News Magazine|
MindMed Completes Enrollment of Phase 2b Trial of MM-120 in Generalized Anxiety Disorder (GAD)news2023-09-12T14:17:29+00:00September 12th, 2023|Medical Device News Magazine|
Signum Surgical Completes Clinical Trial for BioHealxnews2023-09-12T12:52:43+00:00September 12th, 2023|Medical Device News Magazine|
Chung-Ang University Researchers Develop Novel DNA Biosensor for Early Diagnosis of Cervical Cancernews2023-09-08T16:24:22+00:00September 8th, 2023|Medical Device News Magazine|
Veracyte and Gustave Roussy Announce Collaboration to Help Biopharmaceutical Companies Accelerate Development of Novel Cancer Therapiesnews2023-09-06T14:20:18+00:00September 6th, 2023|Medical Device News Magazine|
Applied Cells opens CellQuest Research Grant to Accelerate Cutting-edge Multiple Myeloma Researchnews2023-09-06T14:06:05+00:00September 6th, 2023|Medical Device News Magazine|
